BHRC BLOG AOD-9604 Safety Profile: What Clinical Trials Show AOD-9604 Safety Profile: What Clinical Trials Show When considering any peptide therapy, understanding its safety profile is paramount
Much of the clinical work with DSIP has been small scale, in specific populations (e.g., chronic insomniac patients, disturbed human sleep), and sometimes with injections in hospital/lab settings
Telehealth platforms like Doctronic.ai provide a convenient way to access expert medical advice without leaving home
KEY FEATURES Cagrilintide lyophilised research-grade peptide 10mg per vial Independent HPLC-MS verified to 99.94% purity (CoA on public Lab Results portal) Single-batch fill, single-batch chromatogram no blending across lots Synthesised in accredited contract laboratories with full QA paper trail Crimp-sealed, tamper-evident research vial in unbranded outer packaging Dispatched from Australia on Auspost Express with insulated cold-pack option SPECIFICATIONS Product Name Cagrilintide 10mg Category Metabolic Research Peptides Grade Research grade laboratory use only Quantity 10mg per vial Form Lyophilised powder cake Purity 99.94% verified by HPLC-MS Appearance White to off-white lyophilised solid Storage 28 C lyophilised
The paper highlights GHK-Cus ability to modulate gene expression, affecting a large number of genes related to tissue repair, anti-cancer activity, anti-inflammatory actions, and DNA repair
.webp)
